Cargando…
Decline in infection-related morbidities following drug-mediated reductions in the intensity of Schistosoma infection: A systematic review and meta-analysis
BACKGROUND: Since 1984, WHO has endorsed drug treatment to reduce Schistosoma infection and its consequent morbidity. Cross-sectional studies suggest pre-treatment correlation between infection intensity and risk for Schistosoma-related pathology. However, evidence also suggests that post-treatment...
Autores principales: | Andrade, Gisele, Bertsch, David J., Gazzinelli, Andrea, King, Charles H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333910/ https://www.ncbi.nlm.nih.gov/pubmed/28212414 http://dx.doi.org/10.1371/journal.pntd.0005372 |
Ejemplares similares
-
SCORE Studies on the Impact of Drug Treatment on Morbidity due to Schistosoma mansoni and Schistosoma haematobium Infection
por: King, Charles H., et al.
Publicado: (2020) -
Meta-analysis of Urine Heme Dipstick Diagnosis of Schistosoma haematobium Infection, Including Low-Prevalence and Previously-Treated Populations
por: King, Charles H., et al.
Publicado: (2013) -
Assessment of morbidity due to Schistosoma japonicum infection in China
por: Chen, Ming-gang
Publicado: (2014) -
Associations between infection intensity categories and morbidity prevalence in school-age children are much stronger for Schistosoma haematobium than for S. mansoni
por: Wiegand, Ryan E., et al.
Publicado: (2021) -
Systematic Review and Meta-analysis of the Impact of Chemical-Based Mollusciciding for Control of Schistosoma mansoni and S. haematobium Transmission
por: King, Charles H., et al.
Publicado: (2015)